Echocardiographic Assessment of Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Systematic Review of Literature and a Proposed Algorithm for Assessment by Nagiub, Mohamed et al.
Echocardiographic Assessment of Pulmonary
Hypertension in Infants with Bronchopulmonary
Dysplasia: Systematic Review of Literature and a
Proposed Algorithm for Assessment
Mohamed Nagiub, M.D., F.A.A.P., M.R.C.P.C.H.,* Sam Lee, M.D.,* and Lokesh Guglani, M.D., F.A.A.P.†
*Division of Pediatric Cardiology, Department of Pediatrics, Children Hospital of Richmond, Virginia
Commonwealth University, Richmond, Virginia; and †Division of Pediatric Pulmonary Medicine, The Carman
and Ann Adams Department of Pediatrics, Children’s Hospital of Michigan, Wayne State University School
of Medicine, Detroit, Michigan
Background: As survival and outcomes continue to improve in neonates born prematurely, there is an
increasing need to promptly identify and treat pulmonary hypertension (PHT) in this population. Sev-
eral echocardiographic indices have been used to evaluate for PHT. There is no clear consensus on how
to utilize these parameters speciﬁcally for the evaluation of PHT in infants with chronic lung disease of
prematurity. Objectives: Τhe objectives of the study were (1) to identify the different echocardiographic
techniques for assessment of PHT in infants with chronic lung disease of prematurity in an evidence-
based manner and (2) to establish an echocardiographic screening protocol based on available litera-
ture using different echocardiographic techniques. Methods: We conducted a systematic review of the
literature regarding use of echocardiographic techniques for evaluation of PHT in infants with broncho-
pulmonary dysplasia. On the basis of the available evidence, we came up with a screening algorithm
using various echocardiographic techniques. Results: We identiﬁed nine techniques that had been
employed for detection of PHT noninvasively using echocardiography in 23 studies. Using these echo-
cardiographic parameters, we came up with a ﬂow chart to diagnose PHT in infants born prematurely,
based on presence or absence of tricuspid regurgitation, presence or absence of patent ductus arterio-
sus, and direction of ﬂow. Conclusions: We have proposed a new screening strategy for assessment of
PHT using echocardiography in infants with chronic lung disease of prematurity. Further studies will be
necessary to conﬁrm its validity. (Echocardiography 2015;32:819–833)
Key words: bronchopulmonary dysplasia, prematurity, pulmonary hypertension, screening, echocardi-
ography, chronic lung disease
Pulmonary hypertension (PHT) is a signiﬁcant
comorbidity in infants with bronchopulmonary
dysplasia (BPD). As survival and outcomes con-
tinue to improve in neonates born prematurely,
there is an increasing need to monitor and screen
for these additional comorbidities for their early
diagnosis and treatment. Since echocardiogra-
phy is an important tool in the assessment of
patients with PHT, its role as a screening tool in
patients with BPD is not clearly known.
BPD is classiﬁed into grades of severity on the
basis of need for supplemental O2 and/or mechan-
ical ventilatory support at 28 days of life or 36
completed weeks.1 For most infants with mild
BPD, their clinical course is relatively benign and
PHT is far less common. The group of infants with
moderate-to-severe BPD is the one that requires
close attention. These infants tend to have high
rate of morbidity primarily due to their limited pul-
monary reserve and higher chances of having PHT
as a consequence of their severe lung disease.
Several echocardiographic indices have been
used to identify and characterize the severity of
PHT in BPD.2 However, there are technical chal-
lenges in obtaining adequate echocardiographic
studies in young infants and toddlers. Lack of tri-
cuspid regurgitation (TR) jet may lead to inade-
quate assessment of pulmonary vascular
pressures. Several studies have looked at addi-
tional echocardiographic measurements that can
be used for assessment of right ventricle (RV) or
pulmonary artery (PA) pressures. There is no
clear consensus on how to utilize these parame-
ters and in what speciﬁc situations can these
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parameters be considered useful. We have exten-
sively reviewed the literature regarding use of
echocardiography in evaluation of infants with
BPD and have devised an algorithm for the
assessment of PHT in these patients.
Methods:
The primary aim of this study was to examine the
evidence supporting the use of a screening pro-
tocol for PHT in premature neonates with chronic
lung disease of prematurity. We searched several
electronic databases (PubMed/MEDLINE, Sco-
pus, Cochrane Library, CINAHL [EBSCO Host],
Web of Science) using a predeﬁned search
strategy to identify the relevant studies. The
following search terms were used in our search
strategy: “PHT,” “echocardiography,” “chronic
lung disease of prematurity,” “BPD,” “diagno-
sis,” “screening,” and “systematic review.” The
search methodology and the results obtained
have been summarized in a separate online sup-
plement. Inclusion criteria included neonatal and
pediatric studies (retrospective or prospective
case series, case–control studies, or intervention
studies) that reported the use of echocardio-
graphic techniques for assessment of PHT. Stud-
ies were excluded if they were done in animal
models, described an adult patient population,
discussed only risk factors for development of
PHT, were related to other cardiovascular or lung
anomalies (such as congenital heart disorders or
congenital diaphragmatic hernia), or if they did
not have any echocardiography parameters
included. All studies evaluating the use of echo-
cardiography in the diagnosis of PHT were
included and then screened individually by the
authors. We also searched the bibliographies of
the selected studies to identify additional studies
that may have been overlooked in our initial
search. If the study population comprised infants
and children born prematurely, then those stud-
ies were included in our review and the rest were
excluded. Within the selected studies, further cat-
egorization was made using the type of echocar-
diographic parameters being assessed.
Results:
A total of 120 citations were initially identiﬁed
based on our predeﬁned search criteria (Fig. 1).
We excluded 35 studies, as they were review arti-
cles, 32 studies performed in older age groups
and 17 studies that were concerned mainly with
risk factors. Further screening of the remaining
36 manuscripts led to the exclusion of another
13 manuscripts that either did not satisfy our
inclusion criteria or had one of the exclusion cri-
teria. A total of 23 studies that met our inclusion
and exclusion criteria were ﬁnally selected (Table
I). All the selected studies were either prospective
or retrospective case series or case–control
studies of infants with BPD who underwent
echocardiographic assessment for PHT. About
half of the included studies (13/27) had control
subjects. There were 2 studies that attempted to
classify patients into groups based on the sever-
ity of their BPD, while another 2 studies utilized
pulmonary vascular resistance (PVR) measure-
ments to categorize the subgroups. From these
studies, we identiﬁed 9 techniques that had
been employed for detection of PHT noninva-
sively using echocardiography. These techniques
included tricuspid regurgitation jet velocity
(TRJV), systolic duration to diastolic duration
ratio, tricuspid valve regurgitation to velocity
tissue integral, dynamic compliance, pulmonary
artery capacitance (PAC), pulmonary ﬂow analy-
sis, septal ﬂattening, tissue Doppler study, and
tricuspid systolic motion (TSm).
Studies of Echocardiography Parameters:
Echocardiography is a widely available modality
that can be used as a screening tool for the
assessment of PHT in infants with BPD. The con-
ventional measurements on echocardiography
may not be able to reliably detect PHT. This was
elegantly showed by Mourani et al.3 as they com-
pared the echocardiogram assessments of PHT in
infants with BPD with subsequent cardiac cathe-
terization-based measurements of pulmonary
artery pressure (PAP). Systolic PAP (sPAP) could
be estimated in only 61% (TRJV) of echocardiog-
raphy studies, and there was poor correlation
between echocardiogram and cardiac catheteri-
zation measures of sPAP in these BPD infants. Tri-
cuspid valve regurgitation peak velocity is usually
difﬁcult and may not be reliable in BPD patients
due to associated pulmonary hyperinﬂation and
alteration of cardiac position.4 All the studies that
we reviewed regarding the use of echocardiogra-
phy to assess PHT in BPD infants were divided
into two main categories, depending on pres-
ence or absence of TR jet.
Tricuspid Regurgitation Jet Studies:
TR jet: TR jet dependent studies correlated pul-
monary pressure to crude tricuspid regurgitation
peak velocity. Benatar,5 Skinner et al.,6 Mourani
et al.,7 Roushdy et al.,8 and Stuart et al.9 showed
correlation ranging between 0.19 up to 0.95;
with the incidence of regurgitation detection
ranging between 14% and 80%.10
Systolic to diastolic time ratio: TR jet has been
used to acquire ratio of systolic time to diastolic
time to predict pulmonary pressure in infants
with congenital diaphragmatic hernia. Aggarwal
et al.11 showed reliable TR jet in 83% of these
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patients, though the SD/DD was measurable in
only 45%. The diastolic duration was signiﬁcantly
shorter than that of control subjects
(P < 0.0001), and the SD/DD ratio was signiﬁ-
cantly higher than that of control subjects as well
(P < 0.0001). Similarly, Alkon et al.12 showed the
S:D ratio was signiﬁcantly higher in patients with
PHT than in controls (1.38  0.61 vs.
0.72  0.16, P < 0.001).
TRV/VTI (velocity time integral) ratio: Ajami
et al.13 used ratio between TR velocity and tissue
velocity integral (TRV/VTIm) of the pulmonary
valve Doppler. The authors showed good correla-
tion of this parameter with the PVR measured by
cardiac catheterization (R2 = 0.53; P = 0.008),
having a sensitivity of 71.4% and speciﬁcity of
90% for a PVR >6 Wood Units (WU).
Dynamic compliance (Cdyn): Dyer et al.14 used
TR velocity to measure dynamic compliance that
showed lower peak wall velocity values and lower
Cdyn values in PHT patients than control subjects
(P < 0.01).
Pulmonary artery capacitance: Friedberg
et al.15 used TR velocity to calculate PAC,
which correlated well with values obtained by
cardiac catheterization (r = 0.74, P < 0.0001).
PAC also correlated with RV anterior wall
thickness, which can be a surrogate for RV
work.
Non-TR Jet Studies:
There are several neonatal studies that did not
use TRJV to assess PHT. These have been classiﬁed
as follows:
Figure 1. Search results for systematic review of literature.
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I. Quantitative studies that assessed different
indices in Doppler pulmonary ﬂow,
II. Tissue Doppler image (TDI) studies, or
III. Qualitative assessment of right atrium, right
ventricle, and pulmonary artery diameters.
Quantitative studies: AcT/RVET: Measurement
of the ratio between acceleration time (measured
or corrected) and right ventricle ejection time
(AcT/RVET) (Fig. 2B) has been shown to be inver-
sely correlated with PAP in adults. This measure-
ment was also used in multiple studies done in
younger patients: Subhedar and Shaw,16 Evans
and Archer,17 Benatar,5 Murase and Ishida,18
Cevik et al.,19 Cooper et al.,20 Sehgal et al.,10
Fitzgerald et al.,21 and Fuoron et al.,22 made
similar ratio but he calculated right preejection
time (RPET) and right ejection time (RET) ratio by
M mode instead of Doppler.
Cevik, Benatar, and Fitzgerald showed that
there is a negative correlation between AcT/RVET
versus PAP and PVR index (RPI). They also
showed that AcT/RVET can differentiate vasoac-
tive PHT from the nonvasoactive group in 100%
FiO2. A cutoff value of AcT/RVET of less than 0.31
is considered diagnostic of PHT. Subhedar and
Fuoron showed negative correlation between
ratio and duration of oxygen treatment and
worse chest x-ray ﬁnding for BPD.
Inﬂection time and deceleration time: Inﬂection
time (InT) and deceleration time (DT) are pul-
monary ﬂow velocity measurements that can
be corrected for the heart rate dependence by
dividing the measured values by the square
root of the interval between onset of ejection
(Fig. 3A). Cevik et al.19 and Nakahata et al.23
studied InT and DT, while Roushdy et al.8 stud-
ied only InT in PHT patients. Both indices can
differentiate PHT patients from control and
may also differentiate PHT oxygen responders
versus nonresponders, as well as low-PVR versus
high-PVR patients. Nakahata et al. also sug-
gested that left pulmonary artery ﬂow Doppler
study is more accurate than main pulmonary
or right pulmonary arteries.
Based on their data, both Nakahata et al.
and Roushdy et al. suggested that InT of 6 could
be used as a cutoff value to differentiate
responders versus nonresponders as well as
to differentiate high- and low-PVR groups
(<6 WU/m2 by catheterization).
Figure 2. Echocardiography parameters used for assessment of pulmonary hypertension. A. TDI and Tei index calculation.
B. Pulmonary artery ﬂow analysis. C. Eccentricity index calculation (Lei index). D.Measurement of TAPSE.
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Velocity propagation: Velocity propagation is
based on the principle that changes in the
local pressures due to changes in pulse propa-
gation wave speed will affect the velocity of
blood as well (Fig. 3B). It is measured on the
color M-mode trace of ﬂow in PA by the
tracking of ﬂuid moving at a constant velocity.
Shandas et al.24 found colored M-mode Dopp-
ler-derived velocity propagation (Velprop) corre-
lates better to PVR (R = 0.87) than to pressure
(R = 0.73).
Tricuspid annular plane systolic excursion: Tricus-
pid annular plane systolic excursion (TAPSE) is
a simple echocardiographic measure of RV
ejection fraction that is measured by evaluat-
ing the systolic excursion of the lateral tricus-
pid annulus that provides an estimate of
longitudinal myocardial shortening (Fig. 2D).
TAPSE has been evaluated in adults with PHT
and was also studied in preterm infants by
Koestenberger et al.25 It was suggested by
adult studies that lower TAPSE values occur
with PHT. Since TAPSE values increase in a lin-
ear fashion from the 26th week to the 41st
week of gestation, it can be used as a mea-
sure of RV function in preterm neonates.
Based on normative data from Koestenberger
et al., TAPSE values less than 0.5 cm (which is
the 2 SD from normal in preterm less than
30 weeks gestational age) can be used to
identify PHT in this group of patients.25
Figure 3. Echocardiography images showing the assessment of deceleration index and velocity propagation. A. Deceleration
index, which is the ratio of the difference between inﬂection ﬂow and peak ﬂow to the peak ﬂow. B. Velocity propagation, which
is the ratio of the difference between two distances to the difference between the 2 time points.
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Tissue Doppler studies: Tissue pulse Doppler:
Tissue Doppler imaging (TDI) is a novel way of
using Doppler technique by interrogating a point
on the myocardium rather than blood ﬂow (Fig.
2A). By using a consistent point of reference, TDI
has shown good correlation with cardiac cathe-
terization-based data regarding RV and LV func-
tion. Yates et al.26 showed linear correlation
between BPD category and RV-E/E0 (P = 0.07).
They found signiﬁcant differences in RV-E/E0
between mild versus moderate BPD and also
between mild versus severe BPD (P = 0.03 and
0.004, respectively). Patel et al.27 showed RV-E,
RV-S, RV-IVV (isovolemic velocity) and RV-E0 were
signiﬁcantly lower in PHT versus control (P values
<0.0001, 0.0001, 0.001, and 0.0001, respec-
tively). Septal E0 was signiﬁcantly lower in PHT
patients than control with P-value <0.001. Akcan
et al.28 showed TVE and different sites of E0 mea-
surements (TV-E/E0 medial, TV-E/E0 lateral, and
RV-E/E0) can differentiate BPD from control. Also
it can differentiate different severity of BPD.
Roushdy et al.8 showed that a TSm velocity
cutoff value of 6.16 cm/sec provided the highest
balanced sensitivity (85.7%) and speciﬁcity
(66.7%) to accurately estimate catheter-based
PVR >6 WU/m2. A cutoff value less than
7.62 cm/sec had 100% speciﬁcity to predict PVR
>6 WU/m2. Also there was signiﬁcant negative
correlation between the TSm studied and inva-
sive measurement of PVR (r = 0.511 and P
value = 0.0002).
Tei index (myocardial performance index [MPI]):
Tei index is a measure of global ventricular func-
tion that is calculated on echocardiography by
dividing the sum of isovolumic contraction and
relaxation times with the ejection time.29 Akcan
showed lower IVRT (isovolemic relaxation time)
in control versus BPD (P = 0.001). Patel et al.30
showed RVMPI was signiﬁcantly elevated in the
PHT group (P < 0.0001) with poor correlation
(R2 = 0.05; P = 0.17).
Qualitative studies: Right heart dimensions:
Mourani et al.3 studied correlation between PHT
in infants and children with BPD and their right
heart qualitative indices measured by echocardi-
ography. Septal ﬂattening (which occurred in
84% of cases) showed higher sensitivity of 88%
followed by right ventricular dilatation (84%),
while the highest speciﬁcity was noted for right
ventricular hypertrophy (83%). The least sensi-
tive and least speciﬁc parameter was pulmonary
artery dilatation. The performance of these quali-
tative measures of right heart function was noted
to be better in echocardiograms where a TR jet
could be found, thus limiting their usefulness
when TR jet is not present.
Septal ﬂattening (eccentricity index) (Fig. 2C):
King et al.31 studied reciprocal normalized radius
of curvature (modiﬁed later on as eccentricity
index) for children in control group versus 2
groups of PHT (ﬁrst group RVP <50% systemic
pressure and second one RVP >50% systemic
pressure). Aggarwal et al.32 showed that an
eccentricity index of less than 0.81 could differ-
entiate PHT in congenital diaphragmatic hernia
from control subjects. Also, del Cerro et al.33
reported the use of interventricular septal (IVS)
morphology if TR was not quantiﬁable. In their
study, PHT was diagnosed on the basis of end-
systolic ﬂattening of IVS, with or without RV dila-
tation, using the different patterns (ﬁrst
described by King et al.). This parameter also
showed improvement with older age and with
treatment in their cohort.
List of Indices that Could Be Included in
Echocardiographic Study for Infants with BPD:
In the presence of TR:
• Tricuspid valve jet velocity (pulmonary sys-
tolic pressure) >40 mmHg.
• Ratio of systolic time to diastolic time (SD/
DD) >1.15.
• Ratio of tricuspid valve regurgitation to
velocity time integral (TVR/VTI) >0.14.
With absent TR jet (Table II):
• Tissue Doppler:
a Pulse: RV-IVV <5.2 cm/sec, RV-S (TSM)
<7.6 cm/sec, and RV-E0 less than
4.3 cm/sec.
b MPI >0.38
• TAPSE <0.5 cm
• Left pulmonary artery ﬂow analysis unless
PDA ﬂow happens to occur right to left.
a InTc <4.3 msec
b AT/RVET <0.31
c Deceleration index >0.4
• Eccentricity index of right ventricle (Lei
index): <0.81.
Synthesis of an Echocardiographic Screening
Protocol:
On the basis of the review of the abovemen-
tioned studies, we have synthesized a screening
protocol for PHT in infants and toddlers with
BPD, which utilizes these echocardiographic
parameters in an evidence-based manner (Fig. 4).
In the presence of TR with good regurgitant
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Doppler envelope, TR peak velocity can be used
to predict PAP using the modiﬁed Bernoulli equa-
tion (4 9 [velocity of TR]2) to convert this veloc-
ity to a pressure gradient with cutoff value more
than 3 m/sec. This has a good correlation (up to
0.95) to invasive cardiac catheterization-based
measurement.
In the absence of reliable well-enveloped TR
jet and presence of Pptent ductus arteriosus
(PDA), left pulmonary artery (LPA) ﬂow analysis
can be used rather than main pulmonary artery
(MPA) or right pulmonary artery (RPA). The
parameters included in LPA ﬂow analysis (with
their respective cutoff values) are InTc
(<4.3 msec), AT/RVET (<0.31), and deceleration
index (>0.4).23 In addition, EI and TAPSE can also
be used, but TDI values cannot be used due to
presence of PDA.34
In absence of TR jet and right to left PDA
shunt, either the eccentricity index (<0.81) or
TAPSE (<0.5 cm) can be used, because LPA ﬂow
analysis is unreliable in PDA with right to left
shunt.23 Presence of right to left shunt through
PDA means mean pulmonary artery pressure
(MPAP) is at least above mean systemic pressure.
Also strain and strain rate could possibly be used
in this category but strain/strain rate are still
under investigation for adult PHT.35,36 No pediat-
ric studies using strain measurement for PHT
have been published so far.37–39 In the absence
of reliable TRJ with absence of PDA, any of the
following parameters can be used including: tis-
sue Doppler of right ventricle (with cutoff values
of RV-IVV<5.2 cm/sec, RVS (TSM) <7.6 cm/sec,
and RV-E0 < 4.3 cm/sec); LPA ﬂow analysis;
TAPSE; or eccentricity index.
Discussion:
The development of this echocardiography pro-
tocol is meant to aid clinicians in the screening of
infants who are at high risk for the development
of PHT. This is not meant to replace the use of
cardiac catheterization data, which still remains
the gold standard for the diagnosis of PHT in
infants with BPD. Because echocardiography is
noninvasive, portable, and widely available, the
development of a standardized screening
approach can be helpful in the different clinical
situations that are encountered in infants with
BPD. Even though there are many echocardio-
graphic parameters that have been reported in
the adult literature, these cannot be directly
extrapolated to pediatric age groups due to dif-
ferences in the anatomy and physiology.
Reliable TRJV showed high sensitivity and
speciﬁcity to detect PHT in multiple studies as
discussed before. Unfortunately, PHT can occur
without TR jet or with TR but unreliable Doppler
envelope. Studies showed that a reliable TRJ
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may not be seen in up to 85% of patients with
BPD associated PHT, and qualitative studies gen-
erally have low sensitivity and speciﬁcity in this
situation. Hence, there is a need for a standard-
ized approach toward the echocardiographic
assessment of pediatric PHT and it cannot solely
depend on tricuspid regurgitation or quantita-
tive parameters of right heart side.
Since it was ﬁrst described by Fuoron et al.22
36 years ago, cardiologists have tried to ﬁnd the
most reliable noninvasive echocardiographic
parameter that represent pulmonary pressure
accurately. Czernik et al.40 found echocardio-
graphic ﬁndings can be signiﬁcant by 14 days of
age in detecting PHT in BPD infants versus non-
BPD infants. Murase and Ishida18 found that gesta-
tional age is one of the main determinants for PHT
in very low birthweight (VLBW) infants. PHT was
present in the ﬁrst 48 hours in VLBW with gesta-
tional age more than 30 weeks detected by echo-
cardiography versus who were less than 30 weeks
may not have shown PHT until 14 days of life.
To the best of our knowledge, ours is the only
systemic review of the literature regarding differ-
ent echocardiographic parameters to evaluate
PHT in patients with BPD. On the basis of this
review of all the pediatric studies listed in Table II,
we have proposed an echocardiographic algo-
rithm that can help to identify PHT using other
echocardiographic parameters for speciﬁc situa-
tions such as lack of TR jet, or in the presence of
PDA.
There are limitations to the use of this echo-
cardiography screening approach. The use of this
protocol implies a good knowledge of some of
the less commonly used echocardiographic indi-
ces and this may require special training for
assessment of some of these parameters. There is
signiﬁcant operator variability in pediatric echo-
cardiography, and some of the infants with BPD
can be very challenging in terms of getting a reli-
able echocardiogram done. Cardiac catheteriza-
tion still remains the gold standard for the
diagnosis of PHT in the BPD population, but in
many cases it may not be feasible because of
poor pulmonary reserve in these patients. Some
studies did not report concomitant cardiac cathe-
terization data for the study subjects to validate
their echocardiographic parameters. In addition,
a few echocardiography parameters that we have
discussed were initially evaluated in adult popula-
tions or have been used for the assessment of
PHT in non-BPD populations. Hence, the adop-
tion of a more uniform screening and diagnostic
approach may help to generate more long-term
data regarding these echocardiographic parame-
ters in BPD infants with PHT.
There is increasing recognition of other nonin-
vasive markers of pediatric PHT that are being
considered. Colvin et al.41 recently summarized
the existing literature on the use of biomarkers
for pediatric PHT. These could be developed for
use either alone or in combination with echocar-
diography data and future studies may help
deﬁne a combined approach for pediatric
patients. Even though cardiac MRI is nowadays
considered a better tool for assessment of the
right ventricle than echocardiography, the need
TABLE II
Techniques for Non-TR Quantitative Assessment on Echocardiography
Parameters Technique Figure Echocardiographic Window
Acceleration time/right
ventricular ejection
time (AcT/RVET)
Ratio between acceleration
time and ejection time
2B Parasternal short-axis (base) Doppler
Deceleration index (DI) Ratio between results of subtraction
of inﬂection ﬂow from peak ﬂow
to peak ﬂow
3A Parasternal short-axis (base) Doppler
Velocity propagation (VP) Ratio between result of subtraction
of two distances to result of
subtraction of 2 times
3B Parasternal short-axis (base) colored
M-mode
Tricuspid annular plane
systolic excursion (TAPSE)
TAPSE in mm (ASE) 2D Apical four-chamber M-mode
Tissue Doppler
image (TDI)
TDI (RV-IVV, RV-S, RV-E0, and MPI)
(ASE)*
2A Apical four-chamber TDI
Eccentricity index (EI) Ratio of the length of two perpendicular
minor-axis diameters, one of which
bisected and was perpendicular to
the ventricular septum (ASE)*
2C Parasternal short-axis (papillary muscle level)
TDI = tissue Doppler image; TR = tricuspid regurgitant; IVV = isovolemic velocity.
*From the American Society of Echocardiography (ASE) Guidelines for the Echocardiographic Assessment of the Right Heart in
Adults.44
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for sedation for the former in pediatric patients
makes it a limiting factor for its widespread use.
Our algorithm detects PHT in different ana-
tomical/physiological situations. For PHT with
right to left shunt across a PDA, there is insufﬁ-
cient evidence to support the use of one echocar-
diographic modality over the others. But the
presence of right to left shunt is in itself an indica-
tion that pulmonary pressures are probably
higher than systemic pressures.42 Finally, strain
and strain rate are considered a “black box” in
pediatric PHT. Although it has been studied
extensively in adult literature,35,43 most of the
pediatric literature is still establishing norms for
neonates and assessing the effect of PDA on
strain and strain rate.38,39
Conclusions:
Pediatric PHT has its own unique characteristics
and its assessment cannot be just extrapolated
from the data from adult studies. On the basis of
systematic review of the existing literature, we
have proposed a new echocardiography-based
screening strategy for assessment of PHT in
infants with chronic lung disease of prematurity.
Further studies will be necessary to conﬁrm its
validity.
References
1. Ehrenkranz RA, Walsh MC, Vohr BR, et al: Validation of
the National Institutes of Health consensus deﬁnition of
bronchopulmonary dysplasia. Pediatrics 2005;116:
1353–1360.
2. Slaughter JL, Pakrashi T, Jones DE, et al: Echocardio-
graphic detection of pulmonary hypertension in extre-
mely low birth weight infants with bronchopulmonary
dysplasia requiring prolonged positive pressure ventila-
tion. J Perinatol 2011;31:635–640.
3. Mourani PM, Sontag MK, Younoszai A, et al: Clinical util-
ity of echocardiography for the diagnosis and manage-
ment of pulmonary vascular disease in young children
with chronic lung disease. Pediatrics 2008;121:317–325.
Figure 4. Screening algorithm for assessment of pulmonary hypertension in infants with BPD. TR = tricuspid regurgitation;
RVSP = right ventricular systolic pressure; SD/DD = systolic to diastolic time ratio; VTI = velocity tissue integral; InT = inﬂection
time; AT = acceleration time; RVET = right ventricle ejection time; DI = deceleration index; EI = eccentricity index; MPAP = mean
pulmonary artery pressure; MSAP = mean systemic artery pressure; TAPSE = tricuspid annular plane systolic excursion.
831
Echocardiography for Pulmonary Hypertension
4. Abman SH: Pulmonary vascular disease and bronchopul-
monary dysplasia: Evaluation and treatment of pulmo-
nary hypertension. NeoReviews 2011;12:e645–e651.
5. Benatar A, Clarke J, Silverman M: Pulmonary hyperten-
sion in infants with chronic lung disease: Non-invasive
evaluation and short term effect of oxygen treatment.
Arch Dis Child Fetal Neonatal Ed 1995;72:F14–F19.
6. Skinner JR, Stuart AG, O’Sullivan J, et al: Right heart pres-
sure determination by Doppler in infants with tricuspid
regurgitation. Arch Dis Child 1993;69:216–220.
7. Mourani PM, Mullen M, Abman SH: Pulmonary hyper-
tension in bronchopulmonary dysplasia. Progress Pediatr
Cardiol 2009;27:43–48.
8. Roushdy AM, Ragab I, Abd El Raouf W: Noninvasive
assessment of elevated pulmonary vascular resistance in
children with pulmonary hypertension secondary to con-
genital heart disease: A comparative study between ﬁve
different Doppler indices. J Saudi Heart Assoc 2012;24:
233–241.
9. Stuart BD, Sekar P, Coulson JD, et al: Health-care utiliza-
tion and respiratory morbidities in preterm infants with
pulmonary hypertension. J Perinatol 2013;33:543–547.
10. Sehgal A, Athikarisamy SE, Adamopoulos M: Global myo-
cardial function is compromised in infants with pulmo-
nary hypertension. Acta Paediatr 2012;101:410–413.
11. Aggarwal S, Stockman PT, Klein MD, et al: The right ven-
tricular systolic to diastolic duration ratio: A simple prog-
nostic marker in congenital diaphragmatic hernia? Acta
Paediatr 2011;100:1315–1318.
12. Alkon J, Humpl T, Manlhiot C, et al: Usefulness of the
right ventricular systolic to diastolic duration ratio to pre-
dict functional capacity and survival in children with pul-
monary arterial hypertension. Am J Cardiol 2010;106:
430–436.
13. Ajami GH, Cheriki S, Amoozgar H, et al: Accuracy of
Doppler-derived estimation of pulmonary vascular resis-
tance in congenital heart disease: An index of operability.
Pediatr Cardiol 2011;32:1168–1174.
14. Dyer K, Lanning C, Das B, et al: Noninvasive Doppler tis-
sue measurement of pulmonary artery compliance in
children with pulmonary hypertension. J Am Soc Echocar-
diogr 2006;19:403–412.
15. Friedberg MK, Feinstein JA, Rosenthal DN: Noninvasive
assessment of pulmonary arterial capacitance by echocar-
diography. J Am Soc Echocardiogr 2007;20:186–190.
16. Subhedar NV, Shaw NJ: Changes in pulmonary arterial
pressure in preterm infants with chronic lung disease.
Archives Dis Child Fetal Neonatal Ed 2000;82:F243–F247.
17. Evans NJ, Archer LN: Doppler assessment of pulmonary
artery pressure and extrapulmonary shunting in the acute
phase of hyaline membrane disease. Arch Dis Child
1991;66:6.
18. Murase M, Ishida A: Serial pulsed Doppler assessment of
pulmonary artery pressure in very low birth-weight
infants. Pediatr Cardiol 2000;21:452–457.
19. Cevik A, Kula S, Olgunturk R, et al: Assessment of pulmo-
nary arterial hypertension and vascular resistance by
measurements of the pulmonary arterial ﬂow velocity
curve in the absence of a measurable tricuspid regurgit-
ant velocity in childhood congenital heart disease. Pediatr
Cardiol 2013;34:646–655.
20. Cooper MJ, Tyndall M, Silverman NH: Evaluation of the
responsiveness of elevated pulmonary vascular resistance
in children by Doppler echocardiography. J Am Coll Car-
diol 1988;12:470–475.
21. Fitzgerald D, Evans N, Van Asperen P, et al: Subclinical
persisting pulmonary hypertension in chronic neonatal
lung disease. Arch Dis Child 1994;70:5.
22. Fouron JC, Le Guennec JC, Villemant D, et al: Value of
echocardiography in assessing the outcome of broncho-
pulmonary dysplasia of the newborn. Pediatrics 1980;65:
529–535.
23. Nakahata Y, Hiraishi S, Oowada N, et al: Quantitative
assessment of pulmonary vascular resistance and reactiv-
ity in children with pulmonary hypertension due to con-
genital heart disease using a noninvasive method: New
Doppler-derived indexes. Pediatr Cardiol 2009;30:
232–239.
24. Shandas R, Weinberg C, Ivy DD, et al: Development of a
noninvasive ultrasound color m-mode means of estimat-
ing pulmonary vascular resistance in pediatric pulmonary
hypertension: Mathematical analysis, in vitro validation,
and preliminary clinical studies. Circulation 2001;104:
908–913.
25. Koestenberger M, Nagel B, Ravekes W, et al: Systolic
right ventricular function in preterm and term neonates:
Reference values of the tricuspid annular plane systolic
excursion (TAPSE) in 258 patients and calculation of
Z-score values. Neonatology 2011;100:85–92.
26. Yates AR, Welty SE, Gest AL, et al: Myocardial tissue
Doppler changes in patients with bronchopulmonary
dysplasia. J Pediatr 2008;152:766–770.
27. Patel N, Mills JF, Cheung MM: Assessment of right ven-
tricular function using tissue Doppler imaging in infants
with pulmonary hypertension. Neonatology 2009;96:
193–199; discussion 200–192.
28. Akcan A, Kardelen F, Oygucu S, et al: The efﬁcacy of car-
diac ﬁndings in assessing the outcome in preterms with
bronchopulmonary dysplasia. Indian J Pediatr 2013;80:
896–902.
29. Pellett AA, Tolar WG, Merwin DG, et al: The Tei index:
Methodology and disease state values. Echocardiography
2004;21:669–672.
30. Patel N, Mills JF, Cheung MM: Use of the myocardial per-
formance index to assess right ventricular function in
infants with pulmonary hypertension. Pediatr Cardiol
2009;30:133–137.
31. King ME, Braun H, Goldblatt A, et al: Interventricular
septal conﬁguration as a predictor of right ventricular
systolic hypertension in children: A cross-sectional echo-
cardiographic study. Circulation 1983;68:68–75.
32. Aggarwal S, Stockmann P, Klein MD, et al: Echocardio-
graphic measures of ventricular function and pulmonary
artery size: Prognostic markers of congenital diaphrag-
matic hernia? J Perinatol 2011;31:561–566.
33. Del Cerro MJ, Sabate Rotes A, Carton A, et al: Pulmonary
hypertension in bronchopulmonary dysplasia: Clinical
ﬁndings, cardiovascular anomalies and outcomes. Pediatr
Pulmonol 2014;49:49–59.
34. Parikh R, Negrine RJ, Chikermane A, et al: Assessment of
myocardial function in preterm infants with patent duc-
tus arteriosus using tissue Doppler imaging. Cardiol Young
2015;25:70–75.
35. Li Y, Xie M, Wang X, et al: Right ventricular regional and
global systolic function is diminished in patients with pul-
monary arterial hypertension: A 2-dimensional ultra-
sound speckle tracking echocardiography study. Int J
Cardiovasc Imaging 2013;29:545–551.
36. Naderi N, Ojaghi Haghighi Z, Amin A, et al: Utility of
right ventricular strain imaging in predicting pulmonary
vascular resistance in patients with pulmonary hyperten-
sion. Congest Heart Fail 2013;19:116–122.
37. Pena JL, da Silva MG, Faria SC, et al: Quantiﬁcation of
regional left and right ventricular deformation indices in
healthy neonates by using strain rate and strain imaging.
J Am Soc Echocardiogr 2009;22:369–375.
38. Helfer S, Schmitz L, Buhrer C, et al: Tissue doppler-
derived strain and strain rate during the ﬁrst 28 days of
life in very low birth weight infants. Echocardiography
2014;31:765–772.
39. Han G: Assessment of right ventricular systolic function
using ultrasound speckle tracking imaging in patients
with patent ductus arteriosus. Heart 2011;97:
A124.
Nagiub, Lee and Guglani
832
40. Czernik C, Rhode S, Metze B, et al: Persistently elevated
right ventricular index of myocardial performance in pre-
term infants with incipient bronchopulmonary dysplasia.
PLoS ONE 2012;7:e38352.
41. Colvin KL, Dufva MJ, Delaney RP, et al: Biomarkers for
pediatric pulmonary arterial hypertension - a call to col-
laborate. Front Pediatr 2014;2:7.
42. Musewe NN, Poppe D, Smallhorn JF, et al: Doppler echo-
cardiographic measurement of pulmonary artery pres-
sure from ductal Doppler velocities in the newborn. J Am
Coll Cardiol 1990;15:446–456.
43. Haeck MLA, Scherptong RWC, Marsan NA, et al: Prog-
nostic value of right ventricular longitudinal peak systolic
strain in patients with pulmonary hypertension/clinical
perspective. Circ Cardiovasc Imaging 2012;5:628–636.
44. Rudski LG, Lai WW, Aﬁlalo J, et al: Guidelines for the
echocardiographic assessment of the right heart in
adults: A report from the American Society of Echocardi-
ography endorsed by the European Association of Echo-
cardiography, a registered branch of the European
Society of Cardiology, and the Canadian Society of Echo-
cardiography. J Am Soc Echocardiogr 2010;23:685–713;
quiz 786–688.
Supporting Information
Additional Supporting Information may be found
in the online version of this article:
Data S1. Details of the search methodology
for the systematic review.
833
Echocardiography for Pulmonary Hypertension
